Google News

Recursion prices $200M stock offering as Sanofi picks a partnered drug candidate - Utah Business

Oct 15, 2026, 11:21 PM

Translate article text

Choose a language and wait for the translated text.

Recursion prices $200M stock offering as Sanofi picks a partnered drug candidate  Utah Business